-
My Account
In App
My Account
BSE Live
Oct 24, 16:01Prev. Close
439.35
Open Price
439.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 24, 15:59Prev. Close
439.75
Open Price
436.25
Bid Price (Qty.)
440.80 (1700)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -99.40 | -110.96 | -253.06 | -255.32 | 154.37 | |
| Net CashFlow From Operating Activities | 37.23 | 59.92 | -24.01 | 228.09 | 78.03 | |
| Net Cash Used In Investing Activities | -37.37 | -43.79 | -61.21 | -123.91 | 12.03 | |
| Net Cash Used From Financing Activities | -0.70 | -30.26 | 104.90 | -133.63 | -85.21 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.02 | 0.11 | 0.36 | -0.17 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.84 | -14.11 | 19.79 | -29.09 | 4.68 | |
| Cash And Cash Equivalents Begin of Year | 20.84 | 34.95 | 15.16 | 44.25 | 39.58 | |
| Cash And Cash Equivalents End Of Year | 20.00 | 20.84 | 34.95 | 15.16 | 44.26 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y
